Literature DB >> 11205423

Individual differences in preferences for and responses to four nicotine replacement products.

R West1, P Hajek, F Nilsson, J Foulds, S May, A Meadows.   

Abstract

RATIONALE: With several different forms of nicotine replacement therapy available for smokers, it is useful to know about factors that may influence choice of form.
OBJECTIVE: To examine factors associated with preference for different nicotine replacement products and effectiveness of these products. The simple comparison of success rates between the products has been reported previously.
METHODS: Five hundred and four smokers were invited to rank order four products (gum, patch, nasal spray and inhaler) in terms of preference and were then randomly allocated to receive one of the products for a smoking cessation attempt. They were followed up 1 week, 4 weeks, 12 weeks and 15 weeks later. Ratings of the products were repeated 1 week after the quit date. Mood and physical symptoms were assessed at baseline and at each follow-up visit. Urges to smoke were assessed at all post-quit date sessions. Abstinence was assessed by self-report with expired air carbon monoxide verification.
RESULTS: The patch was the most popular product initially, followed by the spray and inhaler and then the gum. The difference was greater for women than men. However, all smokers quickly came to like whichever product they had been allocated. Smokers who initially preferred the spray or inhaler were heavier smokers than those who preferred the gum or patch. Prior experience of the gum was associated with lower initial preference for it, but did not affect outcome. Prior experience with the patch had no effect on preference or outcome. Being allocated to the preferred product did not increase success at stopping smoking. Women were more successful at stopping smoking on the inhaler than the gum. Among highly dependent smokers, those on the inhaler had a lower relapse rate than those on the other products.
CONCLUSIONS: Regardless of initial preferences, whether patients obtain their preferred form of NRT or one selected for them did not seem to affect outcome. This may be because smokers came to like particular products as they got used to them. Other things being equal, women may be better advised to use inhaler rather than gum and men vice versa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11205423     DOI: 10.1007/s002130000577

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients.

Authors:  A Molyneux; S Lewis; U Leivers; A Anderton; M Antoniak; A Brackenridge; F Nilsson; A McNeill; R West; J Moxham; J Britton
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  Comparison of three nicotine treatments: initial reactions and preferences with guided use.

Authors:  Nina G Schneider; Scott Terrace; Margaret A Koury; Shilpan Patel; Behram Vaghaiwalla; Regina Pendergrass; Richard E Olmstead; Chris Cortner
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City.

Authors:  Kristina B Metzger; Farzad Mostashari; Bonnie D Kerker
Journal:  Am J Public Health       Date:  2005-06       Impact factor: 9.308

4.  Preferences among four combination nicotine treatments.

Authors:  Nina G Schneider; Margaret A Koury; Chris Cortner; Richard E Olmstead; Neil Hartman; Leonard Kleinman; Andrew Kim; Craig Chaya; David Leaf
Journal:  Psychopharmacology (Berl)       Date:  2006-08-01       Impact factor: 4.530

5.  Why do those who request smoking treatment fail to attend the first appointment?

Authors:  Peter Gariti; Sarah Levin; Thomas Whittingham; Daniela Barou; Kyle M Kampman; Kevin Lynch; Chanita Hughes Halbert; Arthur Alterman
Journal:  J Subst Abuse Treat       Date:  2007-10-10

6.  The Association Between Epoxide Hydrolase Genetic Variant and Effectiveness of Nicotine Replacement Therapy in a Han Chinese Population.

Authors:  Fan Wang; Yanlong Liu; Song Guo; Dafang Chen; Hongqiang Sun
Journal:  Neurosci Bull       Date:  2016-10-25       Impact factor: 5.203

7.  Client preferences affect treatment satisfaction, completion, and clinical outcome: a meta-analysis.

Authors:  Oliver Lindhiem; Charles B Bennett; Christopher J Trentacosta; Caitlin McLear
Journal:  Clin Psychol Rev       Date:  2014-06-16

8.  Gender and stimulus control of smoking behavior.

Authors:  Stuart G Ferguson; Mai Frandsen; Michael S Dunbar; Saul Shiffman
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

9.  Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.

Authors:  Robert A Schnoll; Elisa Martinez; Kristina L Tatum; Marcella Glass; Albert Bernath; Daron Ferris; Patrick Reynolds
Journal:  Drug Alcohol Depend       Date:  2009-12-09       Impact factor: 4.492

10.  A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Authors:  Megan E Piper; Stevens S Smith; Tanya R Schlam; Michael C Fiore; Douglas E Jorenby; David Fraser; Timothy B Baker
Journal:  Arch Gen Psychiatry       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.